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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
28.06.2020 Predicting the 
disease 
outcome in 
COVID-19 
positive 
patients 
through 
Machine 
Learning: a 
retrospective 
cohort study 
with Brazilian 
data 
medRix (not 
peer reviewed) 
| pre-print 
 Accurate diagnosis of 
patients with C19 is 
important to offer 
adequate treatment and 
prevent health system 
overload 
 This preliminary 
retrospective study 
explores predicting a poor 
prognosis in positive C19 
patients and possible 
outcomes using machine 
learning 
 Machine learning 
techniques fed with 
demographic and clinical 
data including 
comorbidities can assist 
in the prognostic 
prediction and physician 
decision-making allowing 
a faster response and 
contributing to non-
overload of healthcare 
systems 
Machine 
learning 
2 
26.06.2020 Incidence and 
severity of 
COVID-19 in 
HIV-positive 
persons 
receiving 
antiretroviral 
therapy 
Annals of 
Internal 
Medicine |  
 A cohort study in HIV 
clinics in 60 Spanish 
hospitals between 1 Feb 
and 15 April 2020 to 
describe the incidence 
and severity of C19 
among 77 590 HIV-
positive persons receiving 
ART 
 236 were diagnosed with 
C19, 151 were 
hospitalised, 15 admitted 
to ICU and 20 died 
 HIV-positive patients 
receiving TDF/FTC have 
a lower risk for C19 and 
related hospitalisation 
than those receiving other 
therapies 
HIV-
positive, 
ART 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.06.2020 Epidemiological 
characteristics 
of COVID-19: a 
systematic 
review and 
meta-analysis 
Epidemiology 
& Infection | 
Article 
 The incubation period 
and lag between the 
onset of symptoms and 
first clinical visit for C19 
are longer than other 
respiratory viral 
infections including 
MERS and SARS 
 Quarantine periods 
longer than the 
mandatory 14 days may 
be more justified for 
extreme cases 
Incubation 
period, 
symptom 
onset 
28.06.2020 Assessing the 
nationwide 
impact of 
COVID-19 
mitigation 
policies on the 
transmission 
rate of SARS-
CoV-2 in Brazil 
medRix (not 
peer 
reviewed) | 
pre-print 
 Analysis of the effects of 
547 published 
governmental 
interventions, and 
population adherence, on 
the dynamics of C19 
cases across all 27 
Brazilian states 
 Results show that 
population adherence to 
social distance 
recommendations plays 
an important role in the 
effectiveness of 
interventions 
Mitigation, 
NPI 
3 
 This is a major challenge 
to the control of C19 in 
LMICs 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
28.06.2020 Prevalence of 
SARS-CoV-2 
among 
workers 
returning to 
Bihar gives a 
snapshot of 
COVID across 
India 
medRix (not 
peer 
reviewed) | 
pre-print 
 India has reported the 
fourth highest number of 
confirmed SARS-CoV-2 
cases globally, although 
this is likely an 
underestimate due to little 
community testing 
 Millions of daily laborers 
left cities for their rural 
family homes when India 
partially exited from 
lockdown on 4 May 2020 
 This study tested a near-
random sample of laborers 
returning to the state of 
Bihar to estimate positive 
testing rate for COVID 
across India for a 6-week 
period immediately 
following the initial lifting of 
the India’s lockdown 
 Positive testing rates are 
only moderately correlated 
with, and 21% higher than, 
Indian states’ official 
reports, which are not 
based on random 
sampling 
 Higher prevalence among 
returning laborers may 
also reflect great C19 
spread in crowded poor 
communities such as 
slums 
Prevalence, 
migration 
29.06.2020 Assessment of 
the use and 
quick 
preparation of 
saliva for rapid 
microbiological 
bioRix (not 
peer 
reviewed) | 
pre-print 
 Shortage in swabs for 
collecting nasopharyngeal 
and oropharyngeal 
samples and a shortage in 
RNA extraction kits can 
lead to a backlog in 
sample collection and 
testing 
 This study aimed to 
assess the diagnostic 
Saliva, heat 
4 
diagnosis of 
COVID-19 
performance of direct real 
time RT-PCR detection of 
SARS-CoV-2 in heated 
saliva samples, avoiding 
the RNA isolation step, as 
an alternative and easier-
to-collect clinical sample to 
detect SARS-CoV-2 
compared to the 
diagnostic performance of 
nasopharyngeal and 
oropharyngeal swabs 
 RT-PCR can be performed 
using saliva in an RNA 
extraction free protocol 
with good sensitivity and 
specificity 
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 26.06.2020 Framework for 
managing the 
COVID-19 
infodemic: 
methods and 
results of an 
online, 
crowdsourced 
WHO 
technical 
consultation 
 Journal of 
Medical 
Internet 
Research | 
Article 
 WHO technical online 
consultation on 
responding to the C19 
infodemic  
 594 ideas were 
distilled into a set of 
50 proposed actions 
in 5 action areas in a 
framework for 
managing infodemics 
in heath emergencies 
 6 policy implications 
to consider 
Infodemic, 
framework 
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | 
Article type 
Author(s) 
29.06.2020 Including Immigrants is good policy not just 
during the pandemic, but afterwards too 
CDG | Blog Thomas Ginn 
Janeen Madan 
Keller 
29.06.2020 Worst virus fears are realized in poor or war-
torn countries 
AP | News Gerald Imray  
Joseph Krauss 
29.06.2020 Trial of Oxford COVID-19 vaccine starts in 
Brazil 
University of 
Oxford Medical 
Sciences 
Division | News 
 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
6 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
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C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
8 
COVID-19 
Digest 
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
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Sustainable 
Development 
Data 
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
10 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
11 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
12 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
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About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
